Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.37 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | LCK | P06239 | 1/20 | 0.35 |
| ▸ | FYN | P06241 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trimethylammonium SCHEMBL1377988 | 1.00 | PTGS1 (0.37) | PTGS1AKR1C3FFAR3LCKFYN | |
| Trimethylammonium SCHEMBL141479 | 0.97 | PTGS1 (0.36) | PTGS1AKR1C3FFAR3LCKFYN | |
| Trimethylammonium SCHEMBL141480 | 0.97 | PTGS1 (0.36) | PTGS1AKR1C3FFAR3LCKFYN | |
| Trimethylammonium SCHEMBL27993313 | 0.97 | PTGS1 (0.36) | PTGS1AKR1C3FFAR3LCKFYN | |
| Trimethylammonium SCHEMBL460230 | 0.97 | PTGS1 (0.36) | PTGS1AKR1C3FFAR3LCKFYN | |
| Trimethylammonium SCHEMBL1226065 | 0.97 | PTGS1 (0.36) | PTGS1AKR1C3FFAR3LCKFYN | |
| SCHEMBL133954 | 0.90 | — | — | |
| SCHEMBL871351 | 0.90 | FFAR3 (0.43) | PTGS1AKR1C3FFAR3LCKFYN | |
| SCHEMBL1396002 | 0.90 | FFAR3 (0.43) | PTGS1AKR1C3FFAR3LCKFYN | |
| SCHEMBL15042 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11905491-B2 | Post CMP cleaning compositions | ENTEGRIS, INC. (US) | 2024-02-20 | — | — | US | claimed |
| EP-4225882-A1 | POST CMP CLEANING COMPOSITIONS | Entegris, Inc. (US) | 2023-08-16 | — | — | EP | claimed |
| WO-2022076265-A1 | POST CMP CLEANING COMPOSITIONS | ENTEGRIS, INC. (US) | 2022-04-14 | — | — | WO | claimed |
| EP-1490025-B1 | NANOPARTICULATE COMPOSITIONS OF MAP KINASE INHIBITORS | ELAN PHARMA INT LTD (IE) | 2008-02-13 | — | — | EP | claimed |
| EP-1443912-B1 | COMPOSITIONS HAVING A COMBINATION OF IMMEDIATE RELEASE AND CONTROLLED RELEASE CHARACTERISTICS | ELAN PHARMA INT LTD (IE) | 2007-08-29 | — | — | EP | claimed |
| US-20260071149-A1 | MICROELECTRONIC DEVICE CLEANING COMPOSITION | ENTEGRIS INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12559704-B2 | Microelectronic device cleaning composition | ENTEGRIS, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| US-20260015560-A1 | COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES | ENTEGRIS INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12486473-B2 | Post CMP cleaning composition | ENTEGRIS, INC. (US) | 2025-12-02 | — | — | US | disclosed |
| US-20250277171-A1 | COMPOSITION FOR POST-CMP CLEANING | ENTEGRIS, INC. | 2025-09-04 | — | — | US | disclosed |
| EP-4496875-A1 | POST CMP CLEANING COMPOSITION | Entegris, Inc. (US) | 2025-01-29 | — | — | EP | disclosed |
| EP-4493664-A1 | MICROELECTRONIC DEVICE CLEANING COMPOSITION | Entegris, Inc. (US) | 2025-01-22 | — | — | EP | disclosed |
| EP-2205279-A1 | PHARMACEUTICAL COMBINATION OF ALISKIREN AND VALSARTAN | Novartis Ag (CH) | 2010-07-14 | — | — | EP | disclosed |
| WO-2009045796-A1 | PHARMACEUTICAL COMBINATION OF ALISKIREN AND VALSARTAN | NOVARTIS AG (CH) | 2009-04-09 | — | — | WO | disclosed |
| US-20080206322-A1 | Pharmaceutical Multiparticulate Composit Ion Comprising Mycophenolic Acid or Myco Phenolate Sodium and Combination Compositions with Rapamycin | NOVARTIS AG (CH) | 2008-08-28 | — | — | US | disclosed |
| EP-1791526-A2 | PHARMACEUTICAL MULTIPARTICULATE COMPOSITION COMPRISING MYCOPHENOLIC ACID OR MYCOPHENOLATE SODIUM AND COMBINATION COMPOSITIONS WITH RAPAMYCIN | Novartis AG (CH) | 2007-06-06 | — | — | EP | disclosed |
| WO-2006024479-A2 | PHARMACEUTICAL MULTIPARTICULATE COMPOSITIONS COMPRISING MYCOPHENOLIC ACID OR MYCOPHENOLATE SODIUM AND COMBINATION COMPOSITIONS WITH RAPAMYCIN | NOVARTIS AG (CH) | 2006-03-09 | — | — | WO | disclosed |
| EP-1553917-A1 | FORMULATIONS DESIGNED TO BE APPLIED ON KERATINOUS MATERIAL AND TO BE RINSED | Rhodia Chimie (FR) | 2005-07-20 | — | — | EP | disclosed |
| WO-2004022014-A1 | FORMULATIONS DESIGNED TO BE APPLIED ON KERATINOUS MATERIAL AND TO BE RINSED | RHODIA CHIMIE (FR) | 2004-03-18 | — | — | WO | disclosed |
| WO-2004022680-A2 | POLYMER-BASED TEXTILE RINSING FORMULATION | RHODIA CHIMIE (FR) | 2004-03-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559704-B2 | Microelectronic device cleaning composition | HCN1, KCNH3, ADH1C | PTGS1 3615/4885AKR1C3 1857/4885FFAR3 2298/4885 |
| US-20260071149-A1 | MICROELECTRONIC DEVICE CLEANING COMPOSITION | PHOSPHO1, TET2, CHKB | PTGS1 2436/4885AKR1C3 2954/4885FFAR3 3892/4885 |
| US-20260015560-A1 | COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES | TET2, ASIC1, PIEZO1 | PTGS1 3048/4885AKR1C3 4152/4885FFAR3 3724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.